4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-048507
Options or other derivatives
- President and CEO acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McCarthy Sean A. President and CEO | 2016-01-21 | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 | D | ||
Loading xslF345X03/doc1.xml…